According to Dr. Woitzel, he has had a success rate of >90% in treating borreliosis (lyme) in 500 patients over a 7-year period, with a relapse rate of 1-2% (6 patients with re-onset). In his poor man’s version of phase I & II clinical trials (remember, they don’t have a FDA), he treated and monitored 108 patients over 3 years, with a success rate of 96%. And all this is achieved with an average of 6 treatments per patient over the course of 3 weeks.”
